Key facts
- This page summarizes Peter Maag's Form 4 filing for Miromatrix Medical Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Aug 2022, 09:42.
Peter Maag - 10 Aug 2022 Form 4 Insider Report for Miromatrix Medical Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 10 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Aug 2022, 09:42:10 UTC
- Prior SEC filing
- 06 Jul 2022
- Next SEC filing
- 11 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven J. Conley, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Maag filed Form 4 for Miromatrix Medical Inc. on 16 Aug 2022.
Change
- Previous filing in this sequence was filed on 06 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,788
- Change %
- +58%
- Price
- $0.000000
- Shares after
- 35,009
- Date
- 10 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restricted Stock Units ("RSUs") that will fully vest on the earlier of the next annual meeting or one year from the date of the grant.